No. | The paper's citation list |
|---|
1 | Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine. 2022;13: doi: 10.3389/fendo.2022.864253 |
2 | Multikinase and highly selective kinase inhibitors in the neoadjuvant treatment of patients with thyroid cancer. 2025;6: doi: 10.37349/etat.2025.1002291 |
3 | Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma. 2024;592:112295 doi: 10.1016/j.mce.2024.112295 |
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.
